Home » VANDA PHARMACEUTICAL INITIATED WITH 'BUY'
VANDA PHARMACEUTICAL INITIATED WITH 'BUY'
Analysts at Banc of America Securities initiate coverage of Vanda Pharmaceutical Inc (ticker: VNDA) with a "buy" rating. The target price is set to $14. Newratings (http://www.newratings.com/analyst_news/article_1281879.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May